Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dippin' Dots is a flash-frozen beaded ice cream company that leverages its proprietary cryogenic technology for applications in the life sciences and pharmaceutical industries through its subsidiary, Dippin' Dots Cryogenics. The company's patented process uses liquid nitrogen to flash-freeze biological materials, such as probiotics, bacterial cultures, and vaccines, into small pellets that are optimized for freeze-drying and long-term storage. This technology maintains the integrity of sensitive media cultures and provides a high surface-area-to-volume ratio for efficient processing. Headquartered in Paducah, Kentucky, the company offers both specialized equipment sales and contract manufacturing services to the pharmaceutical, nutraceutical, and agricultural sectors. In 2022, Dippin' Dots was acquired by J&J Snack Foods Corp for $222 million.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dippin' Dots.